Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
When two peptides are combined in a single formulation, the stability of the least stable component determines the overall BUD
The ATTAIN-2 trial , scheduled for August 2025, is assessing weight loss in people with obesity who also have type 2 diabetes
Your body gets the full benefit straight away
This level of weight loss is particularly impactful, as even modest weight reductions can lead to improved health outcomes, including lower blood pressure, improved cholesterol levels, and reduced risk of type 2 diabetes
Because of this, the cost of treatment should be considered as part of long-term health planning
Through these programs, patients can access FDA-approved GLP-1 medications at significantly reduced cash-pay rates compared to retail pharmacy pricing
US$ 28.34
US$ 27.16
US$ 21.30
US$ 25.70
US$ 22.08
US$ 29.78
